{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:16:14Z","timestamp":1778318174869,"version":"3.51.4"},"reference-count":50,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The purpose of this study was to analyze the clinical and biochemical outcome of consecutive patients with acromegaly after microscopic transsphenoidal surgery (MTS) at a single center over an 8-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A retrospective analysis of patients with acromegaly treated via MTS between 2008 and 2015 at the authors\u2019 center was performed. The mean follow-up was 29 months (range 1\u2013120 months). Parameters investigated included tumor size, pre- and postoperative insulin-like growth factor\u2013I, growth hormone levels, pretreatment, perioperative complications, and clinical outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 280 patients with acromegaly were treated surgically at the authors\u2019 center over the abovementioned time frame and were included in analyses. For 231 of these patients, complete follow-up data were available for evaluation. One hundred eighty-eight patients (81%) showed remission initially according to current criteria. So far, 23 of these patients relapsed in the further course, so that on follow-up 165 patients (71%) demonstrated full remission by surgery alone. Most patients in whom remission after surgery failed were treated with somatostatin receptor ligands and\/or dopamine agonists as second-line treatment. The main postoperative complications included transient hyponatremia and diabetes insipidus (13\/280; 4.6%). CSF leakage only occurred in 2 cases (2\/280; 0.7%). No surgery-related death occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>The data underline the effectiveness of MTS in acromegaly. Many patients with recurrent disease or incomplete tumor resection can be successfully managed pharmacologically.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2020.3.focus2061","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T08:21:59Z","timestamp":1591172519000},"page":"E9","source":"Crossref","is-referenced-by-count":6,"title":["Real-life analysis of 280 patients with surgically treated acromegaly: a single-center experience from 2008 to 2015"],"prefix":"10.3171","volume":"48","author":[{"given":"Roman","family":"Rotermund","sequence":"first","affiliation":[{"name":"Department of Neurosurgery,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius M.","family":"Mader","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till","family":"Burkhardt","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Friedrich-Ebert-Krankenhaus, Neumuenster; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Matschke","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Aberle","sequence":"additional","affiliation":[{"name":"IIIrd Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Krajewski","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Clinic Schleswig-Holstein, Campus L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Flitsch","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir-Hossein","family":"Rahvar","sequence":"additional","affiliation":[{"name":"IIIrd Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3171\/2017.12.JNS172318","article-title":"Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases treated at a single tertiary care pituitary center","volume":"130","author":"Agam MS","year":"2019","unstructured":"Agam MS, Wedemeyer MA, Wrobel B, Weiss MH, Carmichael JD, Zada G: Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases treated at a single tertiary care pituitary center. J Neurosurg 130:1576\u20131583, 201910.3171\/2017.12.JNS172318"},{"key":"b2","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.wneu.2017.08.182","article-title":"Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria","volume":"108","author":"Anik I","year":"2017","unstructured":"Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, : Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria. World Neurosurg 108:278\u2013290, 201710.1016\/j.wneu.2017.08.18228887283"},{"key":"b3","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/neuros\/nyx020","article-title":"Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors","volume":"81","author":"Babu H","year":"2017","unstructured":"Babu H, Ortega A, Nuno M, Dehghan A, Schweitzer A, Bonert HV, : Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors. Neurosurgery 81:357\u2013366, 201710.1093\/neuros\/nyx02028368500"},{"key":"b4","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00701-017-3318-6","article-title":"Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications","volume":"159","author":"Chen CJ","year":"2017","unstructured":"Chen CJ, Ironside N, Pomeraniec IJ, Chivukula S, Buell TJ, Ding D, : Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications. Acta Neurochir (Wien) 159:2193\u20132207, 201710.1007\/s00701-017-3318-6"},{"key":"b5","series-title":"Neuroendocrinology","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000371808","article-title":"The history of acromegaly","volume":"103","author":"de Herder WW","year":"2016","unstructured":"de Herder WW: The history of acromegaly. Neuroendocrinology 103:7\u201317, 201610.1159\/00037180825572320"},{"key":"b6","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s11102-017-0832-8","article-title":"Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly","volume":"20","author":"Fahlbusch R","year":"2017","unstructured":"Fahlbusch R, Kleinberg D, Biller B, Bonert V, Buchfelder M, Cappabianca P, : Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly. Pituitary 20:668\u2013675, 201710.1007\/s11102-017-0832-828825168"},{"key":"b7","series-title":"J Clin Endocrinol Metab","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1210\/jc.2011-0168","article-title":"Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients","volume":"96","author":"Famini P","year":"2011","unstructured":"Famini P, Maya MM, Melmed S: Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 96:1633\u20131641, 20112147099810.1210\/jc.2011-0168"},{"key":"b8","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12020-012-9790-0","article-title":"Ectopic acromegaly due to growth hormone releasing hormone","volume":"43","author":"Ghazi AA","year":"2013","unstructured":"Ghazi AA, Amirbaigloo A, Dezfooli AA, Saadat N, Ghazi S, Pourafkari M, : Ectopic acromegaly due to growth hormone releasing hormone. Endocrine 43:293\u2013302, 20132298383110.1007\/s12020-012-9790-0"},{"key":"b9","series-title":"J Clin Endocrinol Metab","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson L","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, : Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933\u20133951, 20142535680810.1210\/jc.2014-2700"},{"key":"b10","series-title":"J Neurosurg Sci","first-page":"11","article-title":"Evaluation of trans-sphenoidal surgery in pituitary GH-secreting micro- and macroadenomas: a comparison between microsurgical and endoscopic approach","volume":"59","author":"Lenzi J","year":"2015","unstructured":"Lenzi J, Lapadula G, D\u2019amico T, Delfinis CP, Iuorio R, Caporlingua F, : Evaluation of trans-sphenoidal surgery in pituitary GH-secreting micro- and macroadenomas: a comparison between microsurgical and endoscopic approach. J Neurosurg Sci 59:11\u201318, 201525658052"},{"key":"b11","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","article-title":"The 2017 World Health Organization classification of tumors of the pituitary gland: a summary","volume":"134","author":"Lopes MBS","year":"2017","unstructured":"Lopes MBS: The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134:521\u2013535, 20172882194410.1007\/s00401-017-1769-8"},{"key":"b12","series-title":"Neuroendocrinology","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000095533","article-title":"Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations","volume":"83","author":"Ludecke DK","year":"2006","unstructured":"Ludecke DK, Abe T: Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology 83:230\u2013239, 200610.1159\/00009553317047388"},{"key":"b13","series-title":"Eur J Endocrinol","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry","volume":"176","author":"Maione L","year":"2017","unstructured":"Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F, : Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur J Endocrinol 176:645\u2013655, 201710.1530\/EJE-16-106428246150"},{"key":"b14","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed S","year":"2006","unstructured":"Melmed S: Medical progress: acromegaly. N Engl J Med 355:2558\u20132573, 20061716713910.1056\/NEJMra062453"},{"key":"b15","series-title":"J Clin Endocrinol Metab","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/jc.2017-02017","article-title":"Efficacy and safety of switching to pasireotide in patients with acromegaly controlled with pegvisomant and first-generation somatostatin analogues (PAPE study)","volume":"103","author":"Muhammad A","year":"2018","unstructured":"Muhammad A, van der Lely AJ, Delhanty PJD, Dallenga AHG, Haitsma IK, Janssen JAMJL, : Efficacy and safety of switching to pasireotide in patients with acromegaly controlled with pegvisomant and first-generation somatostatin analogues (PAPE study). J Clin Endocrinol Metab 103:586\u2013595, 20182915599110.1210\/jc.2017-02017"},{"key":"b16","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11102-017-0797-7","article-title":"Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities","volume":"20","author":"Pivonello R","year":"2017","unstructured":"Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, : Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20:46\u201362, 20172822440510.1007\/s11102-017-0797-7"},{"key":"b17","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3171\/2017.5.JNS163069","article-title":"Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study","volume":"129","author":"Pomeraniec IJ","year":"2018","unstructured":"Pomeraniec IJ, Kano H, Xu Z, Nguyen B, Siddiqui ZA, Silva D, : Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study. J Neurosurg 129:648\u2013657, 20182907678510.3171\/2017.5.JNS163069"},{"key":"b18","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3171\/2016.3.JNS152735","article-title":"Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: matched cohort study","volume":"126","author":"Przybylowski CJ","year":"2017","unstructured":"Przybylowski CJ, Dallapiazza RF, Williams BJ, Pomeraniec IJ, Xu Z, Payne SC, : Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: matched cohort study. J Neurosurg 126:889\u2013896, 20172720314210.3171\/2016.3.JNS152735"},{"key":"b19","series-title":"Nat Rev Endocrinol","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrendo.2012.101","article-title":"The changing face of acromegaly\u2014advances in diagnosis and treatment","volume":"8","author":"Ribeiro-Oliveira A Jr","year":"2012","unstructured":"Ribeiro-Oliveira A Jr, Barkan A: The changing face of acromegaly\u2014advances in diagnosis and treatment. Nat Rev Endocrinol 8:605\u2013611, 20122273327110.1038\/nrendo.2012.101"},{"key":"b20","series-title":"Growth Horm IGF Res","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ghir.2018.03.002","article-title":"Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly","volume":"41","author":"Rotermund R","year":"2018","unstructured":"Rotermund R, Burkhardt T, Rohani Z, Jung R, Aberle J, Flitsch J: Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly. Growth Horm IGF Res 41:64\u201370, 20182955523410.1016\/j.ghir.2018.03.002"},{"key":"b21","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11102-016-0724-3","article-title":"Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center","volume":"19","author":"Sagvand BT","year":"2016","unstructured":"Sagvand BT, Khairi S, Haghshenas A, Swearingen B, Tritos NA, Miller KK, : Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center. Pituitary 19:437\u2013447, 201610.1007\/s11102-016-0724-3"},{"key":"b22","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12020-016-0895-8","article-title":"Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly","volume":"53","author":"Schmid HA","year":"2016","unstructured":"Schmid HA, Brue T, Colao A, Gadelha MR, Shimon I, Kapur K, : Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly. Endocrine 53:210\u2013219, 20162690671310.1007\/s12020-016-0895-8"},{"key":"b23","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11102-017-0827-5","article-title":"Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry","volume":"20","author":"Sch\u00f6fl C","year":"2017","unstructured":"Sch\u00f6fl C, Petroff D, T\u00f6njes A, Grussendorf M, Droste M, Stalla G, : Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry. Pituitary 20:635\u2013642, 201710.1007\/s11102-017-0827-528808855"},{"key":"b24","series-title":"Endocr J","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1507\/endocrj.EJ16-0624","article-title":"Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study","volume":"64","author":"Tahara S","year":"2017","unstructured":"Tahara S, Murakami M, Kaneko T, Shimatsu A: Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study. Endocr J 64:735\u2013747, 201710.1507\/endocrj.EJ16-062428592706"},{"key":"b25","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3171\/2015.4.JNS15102","article-title":"Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma","volume":"124","author":"Zaidi HA","year":"2016","unstructured":"Zaidi HA, Awad AW, Bohl MA, Chapple K, Knecht L, Jahnke H, : Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma. J Neurosurg 124:596\u2013604, 201610.3171\/2015.4.JNS15102"},{"key":"b1","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3171\/2017.12.JNS172318","article-title":"Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases treated at a single tertiary care pituitary center","volume":"130","author":"Agam MS","year":"2019","unstructured":"Agam MS, Wedemeyer MA, Wrobel B, Weiss MH, Carmichael JD, Zada G: Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases treated at a single tertiary care pituitary center. J Neurosurg 130:1576\u20131583, 201910.3171\/2017.12.JNS172318"},{"key":"b2","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.wneu.2017.08.182","article-title":"Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria","volume":"108","author":"Anik I","year":"2017","unstructured":"Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, : Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria. World Neurosurg 108:278\u2013290, 201710.1016\/j.wneu.2017.08.18228887283"},{"key":"b3","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/neuros\/nyx020","article-title":"Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors","volume":"81","author":"Babu H","year":"2017","unstructured":"Babu H, Ortega A, Nuno M, Dehghan A, Schweitzer A, Bonert HV, : Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors. Neurosurgery 81:357\u2013366, 201710.1093\/neuros\/nyx02028368500"},{"key":"b4","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00701-017-3318-6","article-title":"Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications","volume":"159","author":"Chen CJ","year":"2017","unstructured":"Chen CJ, Ironside N, Pomeraniec IJ, Chivukula S, Buell TJ, Ding D, : Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications. Acta Neurochir (Wien) 159:2193\u20132207, 201710.1007\/s00701-017-3318-6"},{"key":"b5","series-title":"Neuroendocrinology","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000371808","article-title":"The history of acromegaly","volume":"103","author":"de Herder WW","year":"2016","unstructured":"de Herder WW: The history of acromegaly. Neuroendocrinology 103:7\u201317, 201610.1159\/00037180825572320"},{"key":"b6","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s11102-017-0832-8","article-title":"Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly","volume":"20","author":"Fahlbusch R","year":"2017","unstructured":"Fahlbusch R, Kleinberg D, Biller B, Bonert V, Buchfelder M, Cappabianca P, : Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly. Pituitary 20:668\u2013675, 201710.1007\/s11102-017-0832-828825168"},{"key":"b7","series-title":"J Clin Endocrinol Metab","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1210\/jc.2011-0168","article-title":"Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients","volume":"96","author":"Famini P","year":"2011","unstructured":"Famini P, Maya MM, Melmed S: Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 96:1633\u20131641, 20112147099810.1210\/jc.2011-0168"},{"key":"b8","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12020-012-9790-0","article-title":"Ectopic acromegaly due to growth hormone releasing hormone","volume":"43","author":"Ghazi AA","year":"2013","unstructured":"Ghazi AA, Amirbaigloo A, Dezfooli AA, Saadat N, Ghazi S, Pourafkari M, : Ectopic acromegaly due to growth hormone releasing hormone. Endocrine 43:293\u2013302, 20132298383110.1007\/s12020-012-9790-0"},{"key":"b9","series-title":"J Clin Endocrinol Metab","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson L","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, : Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933\u20133951, 20142535680810.1210\/jc.2014-2700"},{"key":"b10","series-title":"J Neurosurg Sci","first-page":"11","article-title":"Evaluation of trans-sphenoidal surgery in pituitary GH-secreting micro- and macroadenomas: a comparison between microsurgical and endoscopic approach","volume":"59","author":"Lenzi J","year":"2015","unstructured":"Lenzi J, Lapadula G, D\u2019amico T, Delfinis CP, Iuorio R, Caporlingua F, : Evaluation of trans-sphenoidal surgery in pituitary GH-secreting micro- and macroadenomas: a comparison between microsurgical and endoscopic approach. J Neurosurg Sci 59:11\u201318, 201525658052"},{"key":"b11","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","article-title":"The 2017 World Health Organization classification of tumors of the pituitary gland: a summary","volume":"134","author":"Lopes MBS","year":"2017","unstructured":"Lopes MBS: The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134:521\u2013535, 20172882194410.1007\/s00401-017-1769-8"},{"key":"b12","series-title":"Neuroendocrinology","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000095533","article-title":"Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations","volume":"83","author":"Ludecke DK","year":"2006","unstructured":"Ludecke DK, Abe T: Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology 83:230\u2013239, 200610.1159\/00009553317047388"},{"key":"b13","series-title":"Eur J Endocrinol","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry","volume":"176","author":"Maione L","year":"2017","unstructured":"Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F, : Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur J Endocrinol 176:645\u2013655, 201710.1530\/EJE-16-106428246150"},{"key":"b14","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed S","year":"2006","unstructured":"Melmed S: Medical progress: acromegaly. N Engl J Med 355:2558\u20132573, 20061716713910.1056\/NEJMra062453"},{"key":"b15","series-title":"J Clin Endocrinol Metab","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/jc.2017-02017","article-title":"Efficacy and safety of switching to pasireotide in patients with acromegaly controlled with pegvisomant and first-generation somatostatin analogues (PAPE study)","volume":"103","author":"Muhammad A","year":"2018","unstructured":"Muhammad A, van der Lely AJ, Delhanty PJD, Dallenga AHG, Haitsma IK, Janssen JAMJL, : Efficacy and safety of switching to pasireotide in patients with acromegaly controlled with pegvisomant and first-generation somatostatin analogues (PAPE study). J Clin Endocrinol Metab 103:586\u2013595, 20182915599110.1210\/jc.2017-02017"},{"key":"b16","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11102-017-0797-7","article-title":"Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities","volume":"20","author":"Pivonello R","year":"2017","unstructured":"Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, : Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20:46\u201362, 20172822440510.1007\/s11102-017-0797-7"},{"key":"b17","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3171\/2017.5.JNS163069","article-title":"Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study","volume":"129","author":"Pomeraniec IJ","year":"2018","unstructured":"Pomeraniec IJ, Kano H, Xu Z, Nguyen B, Siddiqui ZA, Silva D, : Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study. J Neurosurg 129:648\u2013657, 20182907678510.3171\/2017.5.JNS163069"},{"key":"b18","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3171\/2016.3.JNS152735","article-title":"Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: matched cohort study","volume":"126","author":"Przybylowski CJ","year":"2017","unstructured":"Przybylowski CJ, Dallapiazza RF, Williams BJ, Pomeraniec IJ, Xu Z, Payne SC, : Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: matched cohort study. J Neurosurg 126:889\u2013896, 20172720314210.3171\/2016.3.JNS152735"},{"key":"b19","series-title":"Nat Rev Endocrinol","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrendo.2012.101","article-title":"The changing face of acromegaly\u2014advances in diagnosis and treatment","volume":"8","author":"Ribeiro-Oliveira A Jr","year":"2012","unstructured":"Ribeiro-Oliveira A Jr, Barkan A: The changing face of acromegaly\u2014advances in diagnosis and treatment. Nat Rev Endocrinol 8:605\u2013611, 20122273327110.1038\/nrendo.2012.101"},{"key":"b20","series-title":"Growth Horm IGF Res","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ghir.2018.03.002","article-title":"Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly","volume":"41","author":"Rotermund R","year":"2018","unstructured":"Rotermund R, Burkhardt T, Rohani Z, Jung R, Aberle J, Flitsch J: Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly. Growth Horm IGF Res 41:64\u201370, 20182955523410.1016\/j.ghir.2018.03.002"},{"key":"b21","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11102-016-0724-3","article-title":"Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center","volume":"19","author":"Sagvand BT","year":"2016","unstructured":"Sagvand BT, Khairi S, Haghshenas A, Swearingen B, Tritos NA, Miller KK, : Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center. Pituitary 19:437\u2013447, 201610.1007\/s11102-016-0724-3"},{"key":"b22","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12020-016-0895-8","article-title":"Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly","volume":"53","author":"Schmid HA","year":"2016","unstructured":"Schmid HA, Brue T, Colao A, Gadelha MR, Shimon I, Kapur K, : Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly. Endocrine 53:210\u2013219, 20162690671310.1007\/s12020-016-0895-8"},{"key":"b23","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11102-017-0827-5","article-title":"Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry","volume":"20","author":"Sch\u00f6fl C","year":"2017","unstructured":"Sch\u00f6fl C, Petroff D, T\u00f6njes A, Grussendorf M, Droste M, Stalla G, : Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry. Pituitary 20:635\u2013642, 201710.1007\/s11102-017-0827-528808855"},{"key":"b24","series-title":"Endocr J","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1507\/endocrj.EJ16-0624","article-title":"Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study","volume":"64","author":"Tahara S","year":"2017","unstructured":"Tahara S, Murakami M, Kaneko T, Shimatsu A: Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study. Endocr J 64:735\u2013747, 201710.1507\/endocrj.EJ16-062428592706"},{"key":"b25","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3171\/2015.4.JNS15102","article-title":"Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma","volume":"124","author":"Zaidi HA","year":"2016","unstructured":"Zaidi HA, Awad AW, Bohl MA, Chapple K, Knecht L, Jahnke H, : Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma. J Neurosurg 124:596\u2013604, 201610.3171\/2015.4.JNS15102"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/48\/6\/article-pE9.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/48\/6\/article-pE9.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/48\/6\/article-pE9.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:38:53Z","timestamp":1778315933000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/48\/6\/article-pE9.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":50,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2020.3.focus2061","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}